Regeneron: Get Used to Disappointment

Leerink's Geoffrey Porges has the details on Regeneron Pharmaceuticals' ( REGN ) disappointing earnings :
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.